These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11177447)

  • 1. Post-exposure prophylaxis after occupational and non-occupational exposures to HIV: an overview of the policies implemented in 27 European countries.
    Rey D; Bendiane MK; Moatti JP; Wellings K; Danziger R; MacDowall W;
    AIDS Care; 2000 Dec; 12(6):695-701. PubMed ID: 11177447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe.
    Almeda J; Casabona J; Simon B; Gerard M; Rey D; Puro V; Thomas T;
    Euro Surveill; 2004 Jun; 9(6):35-40. PubMed ID: 15223890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV prone occupational exposures: epidemiology and factors associated with initiation of post-exposure prophylaxis.
    Zenner D; Tomkins S; Charlett A; Wellings K; Ncube F
    J Epidemiol Community Health; 2009 May; 63(5):373-8. PubMed ID: 19188197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues on antiretroviral post exposure combination prophylaxis.
    Puro V; Ippolito G
    J Biol Regul Homeost Agents; 1997; 11(1-2):11-9. PubMed ID: 9418155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of HIV infection.
    Omrani AS; Freedman A
    Br Med Bull; 2005; 73-74():93-105. PubMed ID: 16207801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure prophylaxis for human immunodeficiency virus infection in the Royal Infirmary of Edinburgh--an audit.
    Manavi K; McMillan A; Paterson J
    Int J STD AIDS; 2004 Feb; 15(2):134-8. PubMed ID: 15006077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of HIV exposure and postexposure prophylaxis among health care workers in Greece.
    Konte V; Nikolopoulos G; Raftopoulos V; Pylli M; Tsiara C; Makri E; Paraskeva D
    Public Health Nurs; 2007; 24(4):337-42. PubMed ID: 17553023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention, safety and prophylactic measures in occupational HIV infection in Italy, the European Union and the USA].
    Papacchini M; Delle Piane R; Palmi S; Tomao P
    Med Lav; 1999; 90(5):681-92. PubMed ID: 10596543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-occupational postexposure HIV prophylaxis: clinical issues and public health questions.
    Mayer KH; Kwong J; Singal R; Boswell S
    Med Health R I; 2000 Jul; 83(7):210-3. PubMed ID: 10934823
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-exposure prophylaxis for HIV infection.
    Rey D
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):431-42. PubMed ID: 21504400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure prophylaxis against human immunodeficiency virus.
    Tolle MA; Schwarzwald HL
    Am Fam Physician; 2010 Jul; 82(2):161-6. PubMed ID: 20642270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a standard HIV post exposure prophylaxis for healthcare workers in Europe.
    Puro V; Cicalini S; De Carli G; Soldani F; Ippolito G;
    Euro Surveill; 2004 Jun; 9(6):40-3. PubMed ID: 15223889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.